![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/neurim-pharmaceuticals-receives-positive-chmp-opinion-on-slenyto-pediatric-prolonged-release-melatonin-for-the-treatment-of-insomnia-in-children-with-neurogenetic-disorders-ngds-302209423.html